A Phase III, Multicenter, Randomized, Double-Blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-Rosette (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial
Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2017.12.018
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2018
Authors
Publisher
Elsevier BV